In a moment when medicine increasingly asks how knowledge can travel faster than the systems built to hold it, Penn Medicine has partnered with OpenEvidence to place an AI clinical decision tool in the hands of roughly 10,000 physicians — not only in Philadelphia's well-resourced hospitals, but across global health initiatives stretching into Botswana and sub-Saharan Africa. The arrangement is less about technological novelty than about a deliberate philosophical choice: that the best available medical evidence should not be a privilege of geography or institutional wealth. It is an attempt, s